Morbid Obesity Clinical Trial
Official title:
Effect of Continuous Intravenous Lidocaine on Early Rehabilitation in Bariatric Surgery. A Randomized Double Blind Controlled Study
Although peroperative intravenous lidocaine has been shown to be useful in early recovery
after colorectal surgery, its beneficial effect on the specific population of obese patients
scheduled for bariatric surgery remained unknown.
Investigators hypothesized that peroperative intravenous lidocaine could decrease
postoperative opioid consumption and improve postoperative recovery
This is a prospective, double-blind, placebo-controlled, monocentric study. We plan to
recruit 180 obese adult patients scheduled for bariatric surgery in a the french university
hospital of Caen.
Exclusion: contra-indications for any aminoamide local anesthetic (allergy, severe hepatic
disease) and for intravenous lidocaine (porphyria, atrioventricular conduction disturbances,
uncontrolled seizure disease), long term opioid consumption, need for a post-operative
follow-up in an intensive care unit, combined surgical procedure excepting cholecystectomy,
pregnancy.
Patients will be randomly allocated to receive either a saline placebo or lidocaine
continuous infusions during surgery. Morphinic consumption will be assessed from the end of
the procedure until the third day after surgery. Secondary criteria will concern
post-operative recovery, pain and postoperative nausea and vomiting, other medical and
surgical complications, and toxicity. Plasma lidocaine concentrations will be measured in
patients who had received lidocaine in order to determine the safety and efficiency of our
infusion protocol.
Our analysis will be a superiority one, alpha risk is 5% and beta risk is 20%, in intention
to treat, with no intermediate analysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03657927 -
A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients
|
N/A | |
Recruiting |
NCT04934826 -
Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass
|
N/A | |
Completed |
NCT03181347 -
The Microbiology of Bariatric Surgery
|
N/A | |
Completed |
NCT03886870 -
Obesity, Lifestyle and Work Intervention
|
N/A | |
Active, not recruiting |
NCT04433338 -
The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery
|
N/A | |
Completed |
NCT03553849 -
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
|
N/A | |
Completed |
NCT05854875 -
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
|
N/A | |
Not yet recruiting |
NCT03203161 -
Registry on Obesity Surgery in Adolescents
|
||
Not yet recruiting |
NCT03601273 -
Bariatric Embolization Trial for the Obese Nonsurgical
|
Phase 1 | |
Recruiting |
NCT02129296 -
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01564732 -
Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
|
N/A | |
Completed |
NCT02033265 -
Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
|
||
Not yet recruiting |
NCT01652105 -
Randomized Trial of Preoperative Diets Before Bariatric Surgery
|
N/A | |
Completed |
NCT01963637 -
Gastric Volumetry by Gastric Tomodensitometry With Gas
|
N/A | |
Completed |
NCT01149512 -
Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program
|
N/A | |
Completed |
NCT01955993 -
Fentanyl Metabolism in Obese Adolescents
|
N/A | |
Terminated |
NCT01759550 -
Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
|
||
Recruiting |
NCT01685177 -
Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient
|
N/A | |
Completed |
NCT02929212 -
Effect of Number of Meals on Metabolism After Weight Loss Surgery
|
N/A | |
Completed |
NCT01675713 -
Lifestyleintervention for the Treatment of Severe Obesity
|
N/A |